Clever Culture Systems (ASX:CC5) said it received a purchase order for an APAS Independence instrument from Novo Nordisk in Europe, and the Danish firm will assess the suitability of the technology for use across their manufacturing network, according to a Monday Australian bourse filing.
The evaluation will assess the performance of both 90 millimeter and contact plate analysis modules for the reading of culture plates used in pharmaceutical environmental monitoring.